BlackRock Fund Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$435M Buy
3,713,470
+43,271
+1% +$4.94M 0.08% 249
2016
Q3
$414M Buy
3,670,199
+124,334
+4% +$13.1M 0.08% 227
2016
Q2
$329M Buy
3,545,865
+236,526
+7% +$20.3M 0.07% 290
2016
Q1
$259M Sell
3,309,339
-62,069
-2% -$4.47M 0.06% 355
2015
Q4
$246M Buy
3,371,408
+150,845
+5% +$10.8M 0.06% 379
2015
Q3
$239M Sell
3,220,563
-47,577
-1% -$3.41M 0.06% 355
2015
Q2
$210M Buy
3,268,140
+189,660
+6% +$13.1M 0.05% 443
2015
Q1
$238M Buy
3,078,480
+164,958
+6% +$12.8M 0.06% 393
2014
Q4
$216M Sell
2,913,522
-186,696
-6% -$13.1M 0.05% 408
2014
Q3
$183M Buy
3,100,218
+70,130
+2% +$4.43M 0.05% 430
2014
Q2
$202M Buy
3,030,088
+88,132
+3% +$5.6M 0.06% 387
2014
Q1
$179M Sell
2,941,956
-88,220
-3% -$5.26M 0.05% 429
2013
Q4
$161M Buy
3,030,176
+327,072
+12% +$17.2M 0.05% 494
2013
Q3
$135M Buy
2,703,104
+66,780
+3% +$3.21M 0.05% 538
2013
Q2
$118M Buy
+2,636,324
New +$115M 0.04% 541

Other funds holding IDXX

BlackRock Fund Advisors's IDXX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Idexx Laboratories (IDXX) stake by 1.2% in Q4 2016, buying an estimated $4.94M and bringing the position to 3,713,470 shares worth $435M. The position accounts for 0.08% of the portfolio, ranked #249.

BlackRock Fund Advisors first reported a position in IDXX in Q2 2013 and has held it in 15 quarters since. 522 funds tracked by Wall St. Rank hold IDXX as of Q4 2016.

  • BlackRock Fund Advisors held 3,713,470 shares of Idexx Laboratories worth $435M as of Q4 2016.
  • BlackRock Fund Advisors bought 43,271 Idexx Laboratories shares in Q4 2016, an estimated $4.94M.
  • Idexx Laboratories made up 0.08% of BlackRock Fund Advisors's portfolio in Q4 2016, its #249 holding.
  • BlackRock Fund Advisors first reported a position in Idexx Laboratories in Q2 2013 and has held it in 15 quarters since.
  • 522 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.